Magnetomotoric Ultrasound (MMUS) in Rectal Cancer
- Conditions
- Rectal Cancer
- Interventions
- Diagnostic Test: Magnetomotoric ultrasound
- Registration Number
- NCT05052086
- Lead Sponsor
- Region Skane
- Brief Summary
Magnetomotoric ultrasound, combines conventional ultrasound with a time-varying magnetic field. The aim is to improve diagnosis of mesolectal lymph nodes.
- Detailed Description
Magnetomotoric ultrasound, combines conventional ultrasound with a time-varying magnetic field. Nanoparticles are injected close to the rectal cancer and migrate to adjacent lymph nodes.The time-varying magnetic field will influence the nano particles in the lymph node enhancing diagnosis of affected lymph nodes. The aim is to improve diagnosis of mesolectal lymph nodes and compare the results of magnetomotoric ultrasound with MRI and final histopathology.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 60
- Rectal cancer
- Scheduled for total mesorectal surgery
- Informed consent
- Not able to give informed consent
- Synchronus colorectal cancer
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Magnetomotoric ultrasound Magnetomotoric ultrasound Magnetomotoric ultrasound in addition to MRI.
- Primary Outcome Measures
Name Time Method Accuracy of mesorectal lymph node diagnosis with MMUS, compared with final histopathology Approximately 1 hour after MMUS Evaluation of the accuracy of MMUS in detecting lymph node metastases in rectal cancer. The results of the MMUS (malignant or benign lymph nodes) will be compared with final histopathology. The accuracy will be expressed in sensitivity (%), specificity (%) and overall accuracy (% correctly staged lymph nodes with MMUS)
Accuracy of mesorectal lymph node diagnosis with MMUS, compared with preoperative MRI Approximately 1 hour after MMUS Evaluation of the accuracy of MMUS in detecting lymph node metastases in rectal cancer in comparison to standard staging (MRI). The results of the MMUS (malignant nodes or benign nodes) will be compared with the results of preoperative MRI (malignant or benign lymph nodes) and the final histopathology. The accuracy will be expressed in sensitivity (%), specificity (%) and overall accuracy (% correctly staged lymph nodes) with MMUS and MRI.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Skane University Hospital, Malmö, section of Surgery
🇸🇪Malmö, Skåne, Sweden